Browsing University of Alaska Anchorage by Subject "vaccination"
Now showing items 1-2 of 2
Vaccination Hesitation: Investigation Why Parents Decline Pediatric Influenza Vaccines in Juneau, AlaskaThe influenza virus is responsible for hundreds of childhood deaths and costs the health care system millions of dollars each year (Hassan, Lewis, Davis, Gebremariam, and Dombkowski, 2009). The influenza vaccine is the most effective intervention for prevention of pediatric influenza, yet many parents decline this vaccine for their children. Studies completed in various geographic locations cite different factors influencing parents who decline pediatric vaccinations. Alaska has the second lowest rate of influenza vaccination in the country (Center for Disease Control [CDC], 2012). The purpose of this project was to understand the factors that influence parental decision to refuse influenza vaccination in Juneau, Alaska. A modified version of the Childhood Influenza Immunization Questionnaire, an instrument based on the Health Belief Model, was utilized to collect data from a convenience sample of parents at a private pediatric practice in Juneau, AK. Statistical analysis revealed the only significant influencing factor on parents’ decisions on whether to vaccinate against influenza was their perception of vaccine risk (p < .001). Information obtained from this study will be used to educate local providers in the community with the goal of enabling said providers to overcome resistance to vaccination hesitancy based on parent perceptions.
Vaccine implementation: Alaska 2017Bacterial meningitis is a serious disease that causes permanent dysfunction or death; adolescents and young adults carry the greatest risk. The national Advisory Committee on Immunization Practices (ACIP) has released vaccine recommendations that include incorporation of meningitis vaccine in to the mandatory school vaccine schedule. Throughout the nation, much of legislative policy has made meningitis vaccination a requirement for public school attendance. Alaska does not have such policy; the purpose of the project was to address this policy need. A secondary project goal was to increase community awareness of bacterial meningitis. Project actions were divided into policy advocacy and community awareness. Policy advocacy included the development of a Policy Brief to Persuade designed for the Alaska legislative health care committee members. A legislative survey to assess willingness to incorporate a required meningitis vaccine schedule into existing Alaska vaccine policy was sent electronically with the policy brief. Community awareness interventions included the development of a Meningitis Education Bundle for healthcare professionals and a Protect Alaska’s Future campaign. The education bundle was distributed to local health establishments on Prince of Wales Island and the campaign information was distributed at the 2017 Prince of Wales Community Health Fair. Project outcomes demonstrated a lack of response to the policy survey. Efforts must continue over time with a deliberate plan to gain legislative support for the incorporation of a meningitis vaccination schedule into existing Alaska vaccine policy, as recommended by the ACIP. Community awareness activities at the health fair were successful and should continue.